News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boehringer Ingelheim Corporation Rethinks Hepatitis Business, Braces For A Rough 2014


4/16/2014 8:09:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Family-owned Boehringer Ingelheim is bracing for a rough 2014. The drugmaker indicated in its 2013 annual report that “we can expect to face challenges,” and that it is not expecting BI, let alone the industry, to experience a significant upswing within the next 12 months. This was not the German company's only downbeat news: BI has also indicated it has stepped out of the interferon-free Hepatitis C race.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES